TY - JOUR
T1 - An international multicenter retrospective study of Pseudomonas aeruginosa nosocomial pneumonia
T2 - Impact of multidrug resistance
AU - Micek, Scott T.
AU - Wunderink, Richard G.
AU - Kollef, Marin H.
AU - Chen, Catherine
AU - Rello, Jordi
AU - Chastre, Jean
AU - Antonelli, Massimo
AU - Welte, Tobias
AU - Clair, Bernard
AU - Ostermann, Helmut
AU - Calbo, Esther
AU - Torres, Antoni
AU - Menichetti, Francesco
AU - Schramm, Garrett E.
AU - Menon, Vandana
N1 - Funding Information:
We recognize Erin N Frazee, PharmD and Heather A Personett, PharmD at the Mayo Clinic for their contributions to data collection and review of the manuscript. The following Independent Ethics Committees or Institutional Review Boards approved the study: St Louis College of Pharmacy, Washington University in St Louis, Northwestern University, Mayo Clinic (United States); Conseil National de l’Ordre des Médecins, Conseil National de l’Informatique et des Libertés, (France); Ethik-Kommission der Medizinischen Fakultät der Ludwig-Maximilians Universität, Ethik-Kommission der Medizinischen Hochschule Hannover, (Germany); Comitato Etico Dell’ Universita’ Cattolica Del Sacro Cuore - Policlinico Universitario, Comitato Etico Toscana Area Vasta Nord Est, (Italy); CEIC Hospital Mutua de Terrassa, CEIC H Vall d Hebron, CEIC Hospital Clinic i Provincial de Barcelona, (Spain). The study was supported by a grant from Cubist Pharmaceuticals. Employees of the sponsor had a role in the study design and critical revision of the manuscript. All authors had full access to all of the data in the study and were responsible for the content of the manuscript and the decision to submit for publication.
Publisher Copyright:
© Micek et al.; licensee BioMed Central.
PY - 2015/5/6
Y1 - 2015/5/6
N2 - Introduction: Pseudomonas aeruginosa nosocomial pneumonia (Pa-NP) is associated with considerable morbidity, prolonged hospitalization, increased costs, and mortality. Methods: We conducted a retrospective cohort study of adult patients with Pa-NP to determine 1) risk factors for multidrug-resistant (MDR) strains and 2) whether MDR increases the risk for hospital death. Twelve hospitals in 5 countries (United States, n = 3; France, n = 2; Germany, n = 2; Italy, n = 2; and Spain, n = 3) participated. We compared characteristics of patients who had MDR strains to those who did not and derived regression models to identify predictors of MDR and hospital mortality. Results: Of 740 patients with Pa-NP, 226 patients (30.5%) were infected with MDR strains. In multivariable analyses, independent predictors of multidrug-resistance included decreasing age (adjusted odds ratio [AOR] 0.91, 95% confidence interval [CI] 0.96-0.98), diabetes mellitus (AOR 1.90, 95% CI 1.21-3.00) and ICU admission (AOR 1.73, 95% CI 1.06-2.81). Multidrug-resistance, heart failure, increasing age, mechanical ventilation, and bacteremia were independently associated with in-hospital mortality in the Cox Proportional Hazards Model analysis. Conclusions: Among patients with Pa-NP the presence of infection with a MDR strain is associated with increased in-hospital mortality. Identification of patients at risk of MDR Pa-NP could facilitate appropriate empiric antibiotic decisions that in turn could lead to improved hospital survival.
AB - Introduction: Pseudomonas aeruginosa nosocomial pneumonia (Pa-NP) is associated with considerable morbidity, prolonged hospitalization, increased costs, and mortality. Methods: We conducted a retrospective cohort study of adult patients with Pa-NP to determine 1) risk factors for multidrug-resistant (MDR) strains and 2) whether MDR increases the risk for hospital death. Twelve hospitals in 5 countries (United States, n = 3; France, n = 2; Germany, n = 2; Italy, n = 2; and Spain, n = 3) participated. We compared characteristics of patients who had MDR strains to those who did not and derived regression models to identify predictors of MDR and hospital mortality. Results: Of 740 patients with Pa-NP, 226 patients (30.5%) were infected with MDR strains. In multivariable analyses, independent predictors of multidrug-resistance included decreasing age (adjusted odds ratio [AOR] 0.91, 95% confidence interval [CI] 0.96-0.98), diabetes mellitus (AOR 1.90, 95% CI 1.21-3.00) and ICU admission (AOR 1.73, 95% CI 1.06-2.81). Multidrug-resistance, heart failure, increasing age, mechanical ventilation, and bacteremia were independently associated with in-hospital mortality in the Cox Proportional Hazards Model analysis. Conclusions: Among patients with Pa-NP the presence of infection with a MDR strain is associated with increased in-hospital mortality. Identification of patients at risk of MDR Pa-NP could facilitate appropriate empiric antibiotic decisions that in turn could lead to improved hospital survival.
UR - http://www.scopus.com/inward/record.url?scp=84930199723&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84930199723&partnerID=8YFLogxK
U2 - 10.1186/s13054-015-0926-5
DO - 10.1186/s13054-015-0926-5
M3 - Article
C2 - 25944081
AN - SCOPUS:84930199723
SN - 1364-8535
VL - 19
JO - Critical Care
JF - Critical Care
IS - 1
M1 - 219
ER -